Entrada Therapeutics (TRDA) Amortizatization of Intangibles (2022 - 2025)
Historic Amortizatization of Intangibles for Entrada Therapeutics (TRDA) over the last 4 years, with Q3 2025 value amounting to $739000.0.
- Entrada Therapeutics' Amortizatization of Intangibles fell 7699.97% to $739000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 4169.3%. This contributed to the annual value of $10.0 million for FY2024, which is 7335.18% up from last year.
- Entrada Therapeutics' Amortizatization of Intangibles amounted to $739000.0 in Q3 2025, which was down 7699.97% from $961000.0 recorded in Q2 2025.
- In the past 5 years, Entrada Therapeutics' Amortizatization of Intangibles registered a high of $3.2 million during Q3 2024, and its lowest value of -$145000.0 during Q2 2022.
- For the 4-year period, Entrada Therapeutics' Amortizatization of Intangibles averaged around $1.2 million, with its median value being $1.3 million (2025).
- Per our database at Business Quant, Entrada Therapeutics' Amortizatization of Intangibles skyrocketed by 568750.0% in 2023 and then plummeted by 7699.97% in 2025.
- Entrada Therapeutics' Amortizatization of Intangibles (Quarter) stood at $104000.0 in 2022, then surged by 1822.12% to $2.0 million in 2023, then grew by 25.41% to $2.5 million in 2024, then tumbled by 70.52% to $739000.0 in 2025.
- Its Amortizatization of Intangibles was $739000.0 in Q3 2025, compared to $961000.0 in Q2 2025 and $1.3 million in Q1 2025.